Nephrology Department, Affiliated Hospital of Shanxi University of Traditional Chinese Medicine, Taiyuan, China.
Department of Pharmaceutical, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2420446. doi: 10.1080/21645515.2024.2420446. Epub 2024 Nov 4.
This study aimed to present an overview of the current status of research and important discoveries about immunotherapy for glomerulonephritis in general using bibliometric analysis. We collected the literature on immunotherapy for glomerulonephritis from the Web of Science (WOS) database for the last 10 years (2014-2024), and we assessed the mapping of knowledge using Citespace. The findings demonstrated that there were 258 articles concerning the immunotherapy for glomerulonephritis, with a faster growth after 2018. The USA, Charite Universitatsmedizin Berlin, and Anders, Hans-Joachim are the nation, organization, and writer with the highest number of publications. The most often cited reference is Rovin BH (2021) as well (5). The best partnerships are formed by prestigious universities and developed countries for glomerulonephritis research on immunotherapy. Three research hotspots in this area are rituximab, adjuvant, and antibody production erythematosus, respectively.
本研究旨在通过文献计量分析，综述一般肾小球肾炎免疫治疗的研究现状和重要发现。我们从 Web of Science（WOS）数据库中收集了过去 10 年（2014-2024 年）关于肾小球肾炎免疫治疗的文献，并使用 Citespace 评估知识图谱。结果表明，有 258 篇关于肾小球肾炎免疫治疗的文章，2018 年后增长较快。美国、Charite Universitatsmedizin Berlin 和 Anders, Hans-Joachim 是发表文章数量最多的国家、组织和作者。引用最多的参考文献是 Rovin BH（2021）（5）。在免疫治疗肾小球肾炎的研究方面，最好的合作伙伴是知名大学和发达国家。该领域的三个研究热点分别是利妥昔单抗、佐剂和抗体产生性红斑狼疮。
